Copyright Reports & Markets. All rights reserved.

Global Non-invasive Parenteral Screening Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Non-invasive Parenteral Screening
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Non-invasive Parenteral Screening by Type
    • 1.3.1 Overview: Global Non-invasive Parenteral Screening Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Non-invasive Parenteral Screening Consumption Value Market Share by Type in 2023
    • 1.3.3 Instruments
    • 1.3.4 Consumables
  • 1.4 Global Non-invasive Parenteral Screening Market by Application
    • 1.4.1 Overview: Global Non-invasive Parenteral Screening Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Diagnostic Laboratories
    • 1.4.3 Hospitals
  • 1.5 Global Non-invasive Parenteral Screening Market Size & Forecast
  • 1.6 Global Non-invasive Parenteral Screening Market Size and Forecast by Region
    • 1.6.1 Global Non-invasive Parenteral Screening Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Non-invasive Parenteral Screening Market Size by Region, (2019-2030)
    • 1.6.3 North America Non-invasive Parenteral Screening Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Non-invasive Parenteral Screening Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Non-invasive Parenteral Screening Market Size and Prospect (2019-2030)
    • 1.6.6 South America Non-invasive Parenteral Screening Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Non-invasive Parenteral Screening Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 GE Healthcare
    • 2.1.1 GE Healthcare Details
    • 2.1.2 GE Healthcare Major Business
    • 2.1.3 GE Healthcare Non-invasive Parenteral Screening Product and Solutions
    • 2.1.4 GE Healthcare Non-invasive Parenteral Screening Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 GE Healthcare Recent Developments and Future Plans
  • 2.2 Philips
    • 2.2.1 Philips Details
    • 2.2.2 Philips Major Business
    • 2.2.3 Philips Non-invasive Parenteral Screening Product and Solutions
    • 2.2.4 Philips Non-invasive Parenteral Screening Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Philips Recent Developments and Future Plans
  • 2.3 Illumina
    • 2.3.1 Illumina Details
    • 2.3.2 Illumina Major Business
    • 2.3.3 Illumina Non-invasive Parenteral Screening Product and Solutions
    • 2.3.4 Illumina Non-invasive Parenteral Screening Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Illumina Recent Developments and Future Plans
  • 2.4 Thermo Fisher Scientific
    • 2.4.1 Thermo Fisher Scientific Details
    • 2.4.2 Thermo Fisher Scientific Major Business
    • 2.4.3 Thermo Fisher Scientific Non-invasive Parenteral Screening Product and Solutions
    • 2.4.4 Thermo Fisher Scientific Non-invasive Parenteral Screening Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.5 Roche
    • 2.5.1 Roche Details
    • 2.5.2 Roche Major Business
    • 2.5.3 Roche Non-invasive Parenteral Screening Product and Solutions
    • 2.5.4 Roche Non-invasive Parenteral Screening Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Roche Recent Developments and Future Plans
  • 2.6 PacBio
    • 2.6.1 PacBio Details
    • 2.6.2 PacBio Major Business
    • 2.6.3 PacBio Non-invasive Parenteral Screening Product and Solutions
    • 2.6.4 PacBio Non-invasive Parenteral Screening Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 PacBio Recent Developments and Future Plans
  • 2.7 Perkinelmer
    • 2.7.1 Perkinelmer Details
    • 2.7.2 Perkinelmer Major Business
    • 2.7.3 Perkinelmer Non-invasive Parenteral Screening Product and Solutions
    • 2.7.4 Perkinelmer Non-invasive Parenteral Screening Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Perkinelmer Recent Developments and Future Plans
  • 2.8 Qiagen
    • 2.8.1 Qiagen Details
    • 2.8.2 Qiagen Major Business
    • 2.8.3 Qiagen Non-invasive Parenteral Screening Product and Solutions
    • 2.8.4 Qiagen Non-invasive Parenteral Screening Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Qiagen Recent Developments and Future Plans
  • 2.9 Agilent Technologies
    • 2.9.1 Agilent Technologies Details
    • 2.9.2 Agilent Technologies Major Business
    • 2.9.3 Agilent Technologies Non-invasive Parenteral Screening Product and Solutions
    • 2.9.4 Agilent Technologies Non-invasive Parenteral Screening Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Agilent Technologies Recent Developments and Future Plans
  • 2.10 BGI Group
    • 2.10.1 BGI Group Details
    • 2.10.2 BGI Group Major Business
    • 2.10.3 BGI Group Non-invasive Parenteral Screening Product and Solutions
    • 2.10.4 BGI Group Non-invasive Parenteral Screening Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 BGI Group Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Non-invasive Parenteral Screening Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Non-invasive Parenteral Screening by Company Revenue
    • 3.2.2 Top 3 Non-invasive Parenteral Screening Players Market Share in 2023
    • 3.2.3 Top 6 Non-invasive Parenteral Screening Players Market Share in 2023
  • 3.3 Non-invasive Parenteral Screening Market: Overall Company Footprint Analysis
    • 3.3.1 Non-invasive Parenteral Screening Market: Region Footprint
    • 3.3.2 Non-invasive Parenteral Screening Market: Company Product Type Footprint
    • 3.3.3 Non-invasive Parenteral Screening Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Non-invasive Parenteral Screening Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Non-invasive Parenteral Screening Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Non-invasive Parenteral Screening Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Non-invasive Parenteral Screening Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Non-invasive Parenteral Screening Consumption Value by Type (2019-2030)
  • 6.2 North America Non-invasive Parenteral Screening Consumption Value by Application (2019-2030)
  • 6.3 North America Non-invasive Parenteral Screening Market Size by Country
    • 6.3.1 North America Non-invasive Parenteral Screening Consumption Value by Country (2019-2030)
    • 6.3.2 United States Non-invasive Parenteral Screening Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Non-invasive Parenteral Screening Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Non-invasive Parenteral Screening Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Non-invasive Parenteral Screening Consumption Value by Type (2019-2030)
  • 7.2 Europe Non-invasive Parenteral Screening Consumption Value by Application (2019-2030)
  • 7.3 Europe Non-invasive Parenteral Screening Market Size by Country
    • 7.3.1 Europe Non-invasive Parenteral Screening Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Non-invasive Parenteral Screening Market Size and Forecast (2019-2030)
    • 7.3.3 France Non-invasive Parenteral Screening Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Non-invasive Parenteral Screening Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Non-invasive Parenteral Screening Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Non-invasive Parenteral Screening Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Non-invasive Parenteral Screening Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Non-invasive Parenteral Screening Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Non-invasive Parenteral Screening Market Size by Region
    • 8.3.1 Asia-Pacific Non-invasive Parenteral Screening Consumption Value by Region (2019-2030)
    • 8.3.2 China Non-invasive Parenteral Screening Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Non-invasive Parenteral Screening Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Non-invasive Parenteral Screening Market Size and Forecast (2019-2030)
    • 8.3.5 India Non-invasive Parenteral Screening Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Non-invasive Parenteral Screening Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Non-invasive Parenteral Screening Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Non-invasive Parenteral Screening Consumption Value by Type (2019-2030)
  • 9.2 South America Non-invasive Parenteral Screening Consumption Value by Application (2019-2030)
  • 9.3 South America Non-invasive Parenteral Screening Market Size by Country
    • 9.3.1 South America Non-invasive Parenteral Screening Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Non-invasive Parenteral Screening Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Non-invasive Parenteral Screening Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Non-invasive Parenteral Screening Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Non-invasive Parenteral Screening Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Non-invasive Parenteral Screening Market Size by Country
    • 10.3.1 Middle East & Africa Non-invasive Parenteral Screening Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Non-invasive Parenteral Screening Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Non-invasive Parenteral Screening Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Non-invasive Parenteral Screening Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Non-invasive Parenteral Screening Market Drivers
  • 11.2 Non-invasive Parenteral Screening Market Restraints
  • 11.3 Non-invasive Parenteral Screening Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Non-invasive Parenteral Screening Industry Chain
  • 12.2 Non-invasive Parenteral Screening Upstream Analysis
  • 12.3 Non-invasive Parenteral Screening Midstream Analysis
  • 12.4 Non-invasive Parenteral Screening Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Non-invasive Parenteral Screening market size was valued at USD 3922.4 million in 2023 and is forecast to a readjusted size of USD 7256.9 million by 2030 with a CAGR of 9.2% during review period.
    Non-invasive Parenteral Screening is a nascent genetic process of examining a fetal cell free DNA present in the mothers blood serum for detecting common fetal aneuploidies. Its main objective is early detection of genetic disorders such as trisomy 21 (Down syndrome), trisomy 18 (Edward syndrome), trisomy 13 (Patau syndrome), and monosomy X (Turner syndrome). It can also detect the blood group and rhesus actor of the fetus. Some of the NIPTs currently available in the global market are MaterniT21 PLUS, Harmony, Panorama, NIFTY, PrenaTest, BambniTest, and others.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    The Global Info Research report includes an overview of the development of the Non-invasive Parenteral Screening industry chain, the market status of Diagnostic Laboratories (Instruments, Consumables), Hospitals (Instruments, Consumables), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Non-invasive Parenteral Screening.
    Regionally, the report analyzes the Non-invasive Parenteral Screening markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Non-invasive Parenteral Screening market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Non-invasive Parenteral Screening market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Non-invasive Parenteral Screening industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Instruments, Consumables).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Non-invasive Parenteral Screening market.
    Regional Analysis: The report involves examining the Non-invasive Parenteral Screening market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Non-invasive Parenteral Screening market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Non-invasive Parenteral Screening:
    Company Analysis: Report covers individual Non-invasive Parenteral Screening players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Non-invasive Parenteral Screening This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Diagnostic Laboratories, Hospitals).
    Technology Analysis: Report covers specific technologies relevant to Non-invasive Parenteral Screening. It assesses the current state, advancements, and potential future developments in Non-invasive Parenteral Screening areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Non-invasive Parenteral Screening market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Non-invasive Parenteral Screening market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
    Market segment by Type
    Instruments
    Consumables
    Market segment by Application
    Diagnostic Laboratories
    Hospitals
    Market segment by players, this report covers
    GE Healthcare
    Philips
    Illumina
    Thermo Fisher Scientific
    Roche
    PacBio
    Perkinelmer
    Qiagen
    Agilent Technologies
    BGI Group
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Non-invasive Parenteral Screening product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Non-invasive Parenteral Screening, with revenue, gross margin and global market share of Non-invasive Parenteral Screening from 2019 to 2024.
    Chapter 3, the Non-invasive Parenteral Screening competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Non-invasive Parenteral Screening market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Non-invasive Parenteral Screening.
    Chapter 13, to describe Non-invasive Parenteral Screening research findings and conclusion.

    Buy now